ArticlePharmacoepidemiology and drug safety2026

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada.

Sylvia Aponte-Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.